Earnings History Data for Anika Therapeutics (ANIK) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Anika Therapeutics

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-03-2025	AH		ANIK	Anika Therapeutics	243.00	-0.14	0.09	0.00	Anika Therapeutics Non-GAAP EPS of -$0.03 misses by $0.12, revenue of $30.6M beats by $1.6M [3/12/2025 4:16 PM]	15.23	-1.87 (-10.98%)	16.80	-0.30 (-1.81%)	14.95 - 29.12	140,505	90,000	957
Anika Therapeutics Non-GAAP EPS of -$0.03 misses by $0.12, revenue of $30.6M beats by $1.6M [3/12/2025 4:16 PM] Anika Reports Fourth Quarter and Full Year 2024 Financial Results [2025-03-12 04:05PM] Anika: Q4 Earnings Snapshot [2025-03-12 04:33PM] Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates [2025-03-12 05:25PM] Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges [2025-03-13 03:09AM] Q4 2024 Anika Therapeutics Inc Earnings Call [2025-03-13 06:43AM]
31-10-2024	PM		ANIK	Anika Therapeutics Inc.	362.82	-0.44	0.01	0.00	Anika Therapeutics Non-GAAP EPS of -$0.25, revenue of $38.8M [10/31/2024 7:46 AM]	17.26	-7.42 (-30.06%)	24.68	0.0 (0.00%)	16.00 - 29.11	387,151	50,000	9,846
Anika Therapeutics Non-GAAP EPS of -$0.25, revenue of $38.8M [10/31/2024 7:46 AM] Anika: Q3 Earnings Snapshot [2024-10-31 07:18AM] Anika Reports Third Quarter 2024 Financial Results [2024-10-31 07:05AM] Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical [2024-10-31 07:00AM] Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of Earnings [Oct-30-24 09:19AM]
08-08-2024	AH		ANIK	Anika Therapeutics Inc.	386.58	N/A	-0.06	-0.06	Anika Therapeutics Non-GAAP EPS of $0.17 misses by $0.03, revenue of $41.9M beats by $1.13M [8/8/2024 4:33 PM]	25.55	-0.13 (-0.51%)	25.68	0.0 (0.00%)	16.54 - 29.11	41,178	40,000	1,898
Anika Therapeutics Non-GAAP EPS of $0.17 misses by $0.03, revenue of $41.9M beats by $1.13M [8/8/2024 4:33 PM]
08-05-2024	AH		ANIK	Anika Therapeutics Inc.	413.72	0.09	0.13	-0.36	Anika Therapeutics Non-GAAP EPS of $0.09 beats by $0.17, revenue of $40.5M beats by $1.36M [5/8/2024 4:15 PM]	25.25	-3.22 (-11.31%)	28.00	-0.47 (-1.65%)	16.54 - 28.67	150,633	60,000	2,050
Anika Therapeutics appoints Steve Griffin as finance chief [5/8/2024 4:37 PM] Anika Therapeutics Non-GAAP EPS of $0.09 beats by $0.17, revenue of $40.5M beats by $1.36M [5/8/2024 4:15 PM]
13-03-2024	AH		ANIK	Anika Therapeutics Inc.	377.59	0.05	-0.15	-0.21	Anika Therapeutics Non-GAAP EPS of $0.05 beats by $0.28, revenue of $42.97M beats by $1.57M [3/13/2024 4:22 PM]	24.48	-0.91 (-3.60%)	27.00	1.60 (6.30%)	16.54 - 29.25	196,084	100,000	49,098
Anika Therapeutics Non-GAAP EPS of $0.05 beats by $0.28, revenue of $42.97M beats by $1.57M [3/13/2024 4:22 PM] Anika Therapeutics to reduce workforce by 9% [3/14/2024 3:10 AM]
02-11-2023	AH		ANIK	Anika Therapeutics Inc.	285.31	N/A	-0.26	-0.05	Anika Therapeutics Non-GAAP EPS of $0.00 beats by $0.35, revenue of $41.5M beats by $3.23M [11/2/2023 4:32 PM]	21.10	2.11 (11.11%)	21.62	2.63 (13.85%)	16.54 - 32.51	225,908	90,000	936
Anika Therapeutics Non-GAAP EPS of $0.00 beats by $0.35, revenue of $41.5M beats by $3.23M [11/2/2023 4:32 PM]
08-08-2023	AH		ANIK	Anika Therapeutics Inc.	322.22	-0.06	-0.27	-0.12	Anika Therapeutics beats Q2 top and bottom line estimates; updates FY23 outlook [8/8/2023 5:31 PM]	19.98	-1.07 (-5.11%)	22.05	1.00 (4.75%)	19.55 - 32.51	189,330	100,000	2,248
Anika Therapeutics beats Q2 top and bottom line estimates; updates FY23 outlook [8/8/2023 5:31 PM]
09-05-2023	AH	4:05 PM ET (May 9)	ANIK	Anika Therapeutics Inc.	378.55	-0.36	-0.29	-0.11	Anika Therapeutics GAAP EPS of -$0.71 misses by $0.37, revenue of $37.9M beats by $0.54M [5/9/2023 4:35 PM]	25.25	-0.04 (-0.16%)	25.29	0.0 (0.00%)	20.12 - 32.51	89,476	70,000	1,817
Anika Therapeutics GAAP EPS of -$0.71 misses by $0.37, revenue of $37.9M beats by $0.54M [5/9/2023 4:35 PM]
06-03-2023	AH	4:05 PM ET (Mar 6)	ANIK	Anika Therapeutics Inc.	464.15	-0.21	-0.15	-0.23	Anika Therapeutics Non-GAAP EPS of -$0.21 beats by $0.01, revenue of $39.6M beats by $1.89M, guidance below consensus [3/6/2023 4:09 PM]	26.03	-2.84 (-9.84%)	28.87	0.0 (0.00%)	19.95 - 32.51	369,843	80,000	925
Anika Therapeutics Non-GAAP EPS of -$0.21 beats by $0.01, revenue of $39.6M beats by $1.89M, guidance below consensus [3/6/2023 4:09 PM]
08-11-2022	AH	4:05 PM ET (Nov 8)	ANIK	Anika Therapeutics Inc.	420.92	-0.05	-0.18	0.05	Anika Therapeutics Non-GAAP EPS of -$0.05 beats by $0.18, revenue of $40.3M beats by $2.71M [11/8/2022 4:40 PM]	29.77	2.40 (8.77%)	27.37	0.0 (0.00%)	19.95 - 41.70	162,747	110,000	1,795
Anika Therapeutics Non-GAAP EPS of -$0.05 beats by $0.18, revenue of $40.3M beats by $2.71M [11/8/2022 4:40 PM] Anika Reports Third Quarter Fiscal 2022 Financial Results [Nov-08-22 04:05PM]
03-08-2022	AH	4:05 PM ET (Aug 3)	ANIK	Anika Therapeutics Inc.	325.64	-0.12	-0.19	0.09	Anika Therapeutics Non-GAAP EPS of -$0.12 beats by $0.09, revenue of $39.7M beats by $1.85M [8/3/2022 4:35 PM]	22.91	-1.76 (-7.15%)	24.68	0.0 (0.00%)	19.95 - 45.81	175,128	50,000	1,939
Anika Therapeutics Non-GAAP EPS of -$0.12 beats by $0.09, revenue of $39.7M beats by $1.85M [8/3/2022 4:35 PM] Anika Reports Second Quarter Fiscal 2022 Financial Results [Aug-03-22 04:05PM]
05-05-2022	AH	4:05 PM ET (May 5)	ANIK	Anika Therapeutics Inc.	313.76	-0.11	-0.24	0.06	Anika Therapeutics Non-GAAP EPS of -$0.11 beats by $0.20, revenue of $36.69M beats by $3.76M [5/5/2022 4:54 PM]	21.06	0.50 (2.43%)	20.56	0.0 (0.00%)	19.95 - 48.37	247,448	80,000	472
Anika Therapeutics Non-GAAP EPS of -$0.11 beats by $0.20, revenue of $36.69M beats by $3.76M [5/5/2022 4:54 PM] Techne (TECH) Beats Q3 Earnings and Revenue Estimates [May-04-22 07:55AM] Anika Reports First Quarter Fiscal 2022 Financial Results [May-05-22 04:05PM]
08-03-2022	AH	4:05 PM ET (Mar 8)	ANIK	Anika Therapeutics Inc.	448.41	-0.23	-0.07	0.12	Anika Therapeutics Non-GAAP EPS of -$0.23 misses by $0.02, revenue of $35.82M beats by $3.77M [3/8/2022 4:28 PM]	25.32	-5.28 (-17.25%)	30.60	0.0 (0.00%)	25.00 - 48.37	69,667	70,000	1,029
Anika Therapeutics Non-GAAP EPS of -$0.23 misses by $0.02, revenue of $35.82M beats by $3.77M [3/8/2022 4:28 PM] Anika Therapeutics stock falls 17% after Barrington, Stephens downgrade on outlook [3/9/2022 11:37 AM] AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Lags Revenue Estimates [Mar-07-22 10:05AM] Anika Reports Fourth Quarter and Year-End 2021 Financial Results [Mar-08-22 04:05PM]
04-11-2021	AH	4:05 PM ET (Nov 4)	ANIK	Anika Therapeutics Inc.	619.61	0.05	0.08	-0.45	Anika Therapeutics EPS beats by $0.06, beats on revenue [11/4/2021 4:46 PM]	45.10	1.78 (4.10%)	43.32	0.0 (0.00%)	32.30 - 48.37	38,384	50,000	316
Anika Therapeutics EPS beats by $0.06, beats on revenue [11/4/2021 4:46 PM] Anika Reports Third Quarter 2021 Financial Results [Nov-04-21 04:05PM] Anika Therapeutics (ANIK) Tops Q3 Earnings and Revenue Estimates [Nov-04-21 06:35PM] Anika Therapeutics, inc (ANIK) Q3 2021 Earnings Call Transcript [Nov-05-21 03:30PM]
05-08-2021	AH	4:05 PM ET (Aug 5)	ANIK	Anika Therapeutics Inc.	588.03	0.09	0.04	0.09	Anika Therapeutics EPS beats by $0.12, beats on revenue [8/5/2021 5:18 PM]	40.45	-0.64 (-1.56%)	41.09	0.0 (0.00%)	32.04 - 48.37	43,344	50,000	593
Anika Reports Second Quarter 2021 Financial Results [Aug-05-21 04:05PM] Anika Therapeutics, inc (ANIK) Q2 2021 Earnings Call Transcript [Aug-06-21 08:01AM]
06-05-2021	AH	4:05 PM ET (May 6)	ANIK	Anika Therapeutics Inc.	584.87	0.06	0.01	0.45	Anika Therapeutics EPS beats by $0.10, beats on revenue [5/6/2021 4:22 PM]	41.99	1.21 (2.97%)	41.43	0.0 (0.00%)	27.54 - 47.48	90,072	90,000	505
Anika Therapeutics EPS beats by $0.10, beats on revenue [5/6/2021 4:22 PM] Anika Reports First Quarter 2021 Financial Results [May-06-21 04:05PM] Anika Therapeutics (ANIK) Surpasses Q1 Earnings and Revenue Estimates [May-06-21 08:05PM] Anika Therapeutics Inc (ANIK) Q1 2021 Earnings Call Transcript [May-07-21 04:31AM]
04-03-2021	AH	4:05 PM ET (Mar 4)	ANIK	Anika Therapeutics Inc.	542.99	0.12	0.11	0.43	Anika Therapeutics EPS beats by $0.01, misses on revenue [3/4/2021 4:21 PM]	34.92	-3.21 (-8.42%)	38.13	0.0 (0.00%)	22.01 - 47.48	196,886	161,657	1,699
Anika Therapeutics EPS beats by $0.01, misses on revenue [3/4/2021 4:21 PM] Anika Therapeutics (ANIK) Reports Q4 Loss, Lags Revenue Estimates [Mar-04-21 07:25PM]
04-11-2020	AH	4:05 PM ET (Nov 4)	ANIK	Anika Therapeutics Inc.	470.55	-0.45	0.13	0.64	Anika Therapeutics EPS beats by $0.06, beats on revenue [11/4/2020 4:24 PM]	33.92	-2.85 (-7.75%)	36.77	0.0 (0.00%)	22.01 - 67.09	142,928	96,091	2,828

30-07-2020	AH	4:05 PM ET (Jul 30)	ANIK	Anika Therapeutics Inc.	500.91	0.09	-0.21	0.67	Anika Therapeutics EPS beats by $0.23, beats on revenue [7/30/2020 4:08 PM]	36.39	-0.78 (-2.10%)	37.00	-0.17 (-0.46%)	22.01 - 75.72	70,405	96,846	1,744